BioSpace News Archive

BioMidwest

American Brain Tumor Association Announces $50-Million Fundraising Campaign to Accelerate Research, Improve Lives of Brain Tumor Patients

A champion of the brain tumor community for 50 years running, the American Brain Tumor Association has launched its most ambitious undertaking yet – a five-year, $50-million fundraising campaign called Meet Hope Head On.

August 22, 2023
·
3 min read
Biotech Beach

ScienceMedia’s SMi Trial™ Receives Heightened Interest for Supporting Diversity and Inclusion in Clinical Trials for Underrepresented Populations

SMi Trial™, ScienceMedia’s protocol compliance and risk-based training for clinical trials, is receiving outstanding praise from sponsors for their recently added training materials on recruiting diverse and underrepresented patient populations.

August 22, 2023
·
3 min read
FDA

Regenesis Achieves FDA Clearance for the New Reprieve by Regenesis™ Device

Regenesis Biomedical, Inc., a medical device company focused on safe, non-drug, pain management, announced today commercialization of the new Reprieve by Regenesis™ device (Reprieve).

August 22, 2023
·
1 min read
Business

BioLineRx to Report Second Quarter 2023 Results on August 30, 2023

BioLineRx Ltd. announced today it will release its unaudited financial results for the quarter ended June 30, 2023 on Wednesday, August 30, 2023, before the U.S. markets open.

August 22, 2023
·
1 min read
BioCapital

Novavax’s Updated Protein-based XBB COVID Vaccine Induced Neutralizing Responses Against Emerging Subvariants, Including EG.5.1 and XBB.1.16.6

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that its updated protein-based XBB COVID vaccine candidate induced neutralizing antibody responses to the EG.5.1 and XBB.1.16.6 subvariants in small animal and non-human primate studies.

August 22, 2023
·
10 min read
Pharm Country

Acurx Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference September 11-13, 2023

Acurx Pharmaceuticals, Inc. announced today that David P. Luci , President & CEO, will present at the H.C. Wainwright 25th Annual Global Investment Conference.

August 22, 2023
·
2 min read
Business

Exavir Therapeutics Receives $3M Award from NIH / NIAID to Advance Ultra-Long-Acting Integrase Inhibitor XVIR-110

Exavir Therapeutics today announced that the company has received a $3M award from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institute of Health (NIH), to support the development of XVIR-110.

August 22, 2023
·
2 min read
Fabbrica Italiana Sintetici (F.I.S.) Selects Kinaxis for Supply Chain Planning

Kinaxis® Inc., the leading supply chain management platform, was selected by F.I.S. - Fabbrica Italiana Sintetici S.p.A. to enable concurrent planning in its supply chain.

August 22, 2023
·
2 min read
BioMidwest

LifePort Liver Transporter by Organ Recovery Systems Wins Fast Company’s 2023 Innovation by Design Award in the ‘Health’ Category

Organ Recovery Systems is honored to announce that its LifePort Liver Transporter was selected as the winner in the ‘Health’ category in Fast Company’s Innovation by Design Awards for 2023.

August 22, 2023
·
4 min read
Business

Kane Biotech to Release Second Quarter 2023 Financial Results on Aug 29, 2023 – Conference Call to Follow

Kane Biotech Inc. will announce its second quarter 2023 financial results after market close on Tuesday, August 29, 2023.

August 22, 2023
·
3 min read